4 Healthcare Stock Stories Ready For a Tuesday Checkup

Eli Lilly and Co. (NYSE:LLY): Closing price $51.79

Experts on Alzheimer’s say that they are ready to protest Medicare’s newly-issued draft guidelines, which would only pay for an Eli Lilly and Co. diagnostic test for the disease if patients were participating in clinical trials for it. Both Lilly and the Alzheimer’s Association have released statements professing disappointment with the decision by the United States Centers for Medicare & Medicaid Services, which pointed to “insufficient” evidence that the tests may enhance patient care. The agency that oversees Medicare did cite evidence that the tests could be useful to rule out Alzheimer’s in certain cases that are difficult to diagnose, and to help identify patients who might be good candidates for clinical trials seeking better treatments, or prevention strategies for the disease.

Are these stocks a buy or sell? Let us help you decide. LLY